AUPH Aurinia Pharmaceuticals Inc

$5.6 +2.56%

753,566 Shares Traded
908,224 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $1.31 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-12.58%
If Intiated One Month Ago, Shorts Have Realized a Return of:5.86%
If Initiated Five Days ago, Shorts Have Realized a Return of:-3.21%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 11.14%
Short Interest9.36 million
Float84.05 million
Short Ratio8.67
Market Cap$458.92 million
Market Maker ActivityDaily Short Volume


Aurinia Enhances Research, Development, and Scientific Expertise with the Appointment of Michael Hayden to its Board of Directors (Business Wire)
Aurinia Named Company of the Year by LifeSciences BC (Business Wire)
Aurinia Pharmaceuticals: Will AURORA Light The Way To Voclosporin's Approval? (SeekingAlpha)
Aurinia Pharmaceuticals Launches New Lupus Nephritis Disease Awareness Program (Business Wire)
Premarket analyst action - healthcare (SeekingAlpha)
Aurinia Enhances Commercial and Business Development Expertise with the Appointment of Joseph P. Hagan to its Board of Directors (Business Wire)
Aurinia to Present at Leerink Partners 7th Annual Global Healthcare Conference (Business Wire)
Aurinia Pharmaceuticals: Potential Rewards Far Outweigh The Risks (SeekingAlpha)
Aurinia Pharmaceuticals' Voclosporin: A Blockbuster Drug Hidden In Plain Sight? (SeekingAlpha)
Bristol-Myers Squibb's Abatacept Compared Against Aurinia Pharmaceuticals' Voclosporin In The Treatment Of Lupus Nephritis Patients (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 49.3%

Earnings Stats

PE Ratio -8.95
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $5.95
50 Day Moving Average $5.17
52 Week High $10.54
52 Week Low $3.23

Data provided for free by IEX. Questions? Read the FAQ